219 related articles for article (PubMed ID: 22634283)
1. Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors.
McDonald CB; Buffa L; Bar-Mag T; Salah Z; Bhat V; Mikles DC; Deegan BJ; Seldeen KL; Malhotra A; Sudol M; Aqeilan RI; Nawaz Z; Farooq A
J Mol Biol; 2012 Sep; 422(1):58-74. PubMed ID: 22634283
[TBL] [Abstract][Full Text] [Related]
2. Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.
Schuchardt BJ; Bhat V; Mikles DC; McDonald CB; Sudol M; Farooq A
Biochemistry; 2013 Dec; 52(51):9223-36. PubMed ID: 24308844
[TBL] [Abstract][Full Text] [Related]
3. Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch.
Schuchardt BJ; Mikles DC; Bhat V; McDonald CB; Sudol M; Farooq A
J Mol Recognit; 2015 Apr; 28(4):220-31. PubMed ID: 25703206
[TBL] [Abstract][Full Text] [Related]
4. Biophysical analysis of binding of WW domains of the YAP2 transcriptional regulator to PPXY motifs within WBP1 and WBP2 adaptors.
McDonald CB; McIntosh SK; Mikles DC; Bhat V; Deegan BJ; Seldeen KL; Saeed AM; Buffa L; Sudol M; Nawaz Z; Farooq A
Biochemistry; 2011 Nov; 50(44):9616-27. PubMed ID: 21981024
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the role of the WW2 domain on tandem WW-PPxY motif interactions of oxidoreductase WWOX.
Rotem-Bamberger S; Fahoum J; Keinan-Adamsky K; Tsaban T; Avraham O; Shalev DE; Chill JH; Schueler-Furman O
J Biol Chem; 2022 Aug; 298(8):102145. PubMed ID: 35716775
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.
Farooq A
Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954
[TBL] [Abstract][Full Text] [Related]
7. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
8. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway.
Webb C; Upadhyay A; Giuntini F; Eggleston I; Furutani-Seiki M; Ishima R; Bagby S
Biochemistry; 2011 Apr; 50(16):3300-9. PubMed ID: 21417403
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic disorder and amino acid specificity modulate binding of the WW2 domain in kidney and brain protein (KIBRA) to synaptopodin.
Kwok E; Rodriguez DJ; Kremerskothen J; Nyarko A
J Biol Chem; 2019 Nov; 294(46):17383-17394. PubMed ID: 31597702
[TBL] [Abstract][Full Text] [Related]
10. Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity.
Schuchardt BJ; Mikles DC; Hoang LM; Bhat V; McDonald CB; Sudol M; Farooq A
FEBS J; 2014 Dec; 281(24):5532-51. PubMed ID: 25283809
[TBL] [Abstract][Full Text] [Related]
11. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.
Chen S; Wang H; Huang YF; Li ML; Cheng JH; Hu P; Lu CH; Zhang Y; Liu N; Tzeng CM; Zhang ZM
Mol Cancer; 2017 Jul; 16(1):128. PubMed ID: 28724435
[TBL] [Abstract][Full Text] [Related]
12. Systematic profiling and identification of the peptide-mediated interactions between human Yes-associated protein and its partners in esophageal cancer.
Chen F; Wang Q; Mu Y; Sun S; Yuan X; Shang P; Ji B
J Mol Recognit; 2022 Mar; 35(3):e2947. PubMed ID: 34964176
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase.
Schuchardt BJ; Bhat V; Mikles DC; McDonald CB; Sudol M; Farooq A
Biochimie; 2014 Jun; 101():192-202. PubMed ID: 24472438
[TBL] [Abstract][Full Text] [Related]
14. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
Sangadala S; Metpally RP; Reddy BV
J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
[TBL] [Abstract][Full Text] [Related]
15. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
[TBL] [Abstract][Full Text] [Related]
16. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
[TBL] [Abstract][Full Text] [Related]
17. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.
Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W
Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.
Salah Z; Bar-mag T; Kohn Y; Pichiorri F; Palumbo T; Melino G; Aqeilan RI
Cell Death Dis; 2013 Jan; 4(1):e480. PubMed ID: 23370280
[TBL] [Abstract][Full Text] [Related]
19. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
Li J; Liu J; Ren Y; Yang J; Liu P
Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the WWOX Protein Regulates Its Interaction with p73.
Lahav N; Rotem-Bamberger S; Fahoum J; Dodson EJ; Kraus Y; Mousa R; Metanis N; Friedler A; Schueler-Furman O
Chembiochem; 2020 Jul; 21(13):1843-1851. PubMed ID: 32185845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
